What We're Reading: Page 111
Industry reads hand-picked by our editors
Feb 13, 2023
Feb 10, 2023
-
NBC News
Fungal infections are becoming more common. Why isn’t there a vaccine?
-
Bloomberg
Advent, CVC Are Among Suitors for €3 Billion Viatris OTC Assets
-
The Wall Street Journal
Layoffs and Shutdowns Hit Biotech Industry in U-Turn
-
In The Pipeline
Molnupiravir Mutations in the Wild
Feb 09, 2023
-
The Wall Street Journal
Pfizer, Novartis, Merck Executives Say They Are Hunting for Deals Again
-
The New Yorker
The Promise of a New Alzheimer’s Drug
-
Reuters
Why Europe’s drug shortages may get worse
-
Science News
Disorder or difference? Autism researchers face off over field’s terminology
Feb 08, 2023
-
Bloomberg
Nestlé’s $6,000 Peanut Allergy Pill Has Been a Dud
-
Disorder or difference? Autism researchers face off over field’s terminology
-
Scientific American
COVID Rebound Can Happen Even without Paxlovid
-
Healthcare Dive
CVS buys Oak Street Health for $10.6B
Feb 07, 2023
-
The New York Times
‘Miracle’ Cystic Fibrosis Drug Kept Out of Reach in Developing Countries
-
Axios
Biden to push for expanded insulin caps, Medicaid coverage in SOTU
-
Nature
What the WHO’s new treaty could mean for the next pandemic
-
The Wall Street Journal
CVS Nearing $10.5 Billion Deal for Primary-Care Provider Oak Street Health
Previous
